Cardiology – MPHCTC

STUDY TYPE (EN)	LOCATION (EN)	COMPANY (EN)	BRANCH (EN)	INVESTIGATOR	PHASE (EN)	STUDY TITLE (EN)	STATUS (EN)	LINK (EN)
CLINICAL TRIAL	IZMIR MPH	BAYER TURK KIMYA	CARDIOLOGY	PROF DR CIHAN ALTIN	PHASE 3	A Multicenter, International, Randomized, Placebo Controlled, Double-blind, Parallel Group and Event Driven Phase 3 Study of the Oral FXIa Inhibitor Asundexian (BAY 2433334) for the Prevention of Ischemic Stroke in Male and Female Participants Aged 18 Years and Older After an Acute Non-cardioembolic Ischemic Stroke or High-risk TIA	COMPLETED	https://clinicaltrials.gov/study/NCT05686070
CLINICAL TRIAL	IZMIR MPH	MERCK SHARP DOHME ILACLARI LTD. STI.	CARDIOLOGY	PROF DR ISTEMIHAN TENGIZ	PHASE 3	A Randomized Parallel-Group, Placebo-Controlled, Double-Blind, Event-Driven, Multi-Center Pivotal Phase III Clinical Outcome Trial of Efficacy and Safety of the Oral sGC Stimulator Vericiguat in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) - VerICiguaT GlObal Study in Subjects With Heart Failure With Reduced EjectIon FrAction (VICTORIA)	COMPLETED	https://clinicaltrials.gov/study/NCT02861534
CLINICAL TRIAL	IZMIR MPH	MERCK SHARP DOHME ILACLARI LTD. STI.	CARDIOLOGY	PROF DR CIHAN ALTIN	PHASE 3	A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction	COMPLETED	https://clinicaltrials.gov/study/NCT05093933
STUDY TYPE (EN)	LOCATION (EN)	COMPANY (EN)	BRANCH (EN)	INVESTIGATOR	PHASE (EN)	STUDY TITLE (EN)	STATUS (EN)	LINK (EN)